Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of cell culture-based vs egg-based trivalent influenza vaccines in adults and elderly
2007-002872-32Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of influenza vaccine in influenza (2 arms), sponsored by Novartis. Primary endpoints: Safety endpoints and Immunogenicity endpoints. Started Aug 2007; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-002872-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002872-32.